EU Authorised Representative for Medical Devices and IVDs Across Europe
For non-EU manufacturers, bringing medical devices or in vitro diagnostic devices into the European market involves more than product quality, technical documentation and regulatory preparation. Before a device can be placed on the European market, the manufacturer must appoint an EU Authorized Representative based within the European Union and formally recognised as the manufacturer’s authorised representative. This role is essential under the Medical Device Regulation and the In Vitro Diagnostic Medical Device Regulation because regulators need a responsible local party who can communicate, provide documentation and support compliance activities when required. An eu-authorized-representative is far more than just a name printed on a label. They serve as the legal presence of a non-EU manufacturer and play a vital role in ensuring market access, regulatory trust and ongoing post-market accountability.
Why an EU Authorized Representative Is Required
European regulations for medical devices aim to safeguard patients, healthcare providers and users by ensuring every product entering the market has a defined chain of responsibility. When a manufacturer is based outside the European Union, regulators cannot always deal with that manufacturer directly in the same practical way they would with a local company. This is exactly where the EU Authorized Representative becomes essential. The representative offers a formal European presence and acts as the official contact for Competent Authorities, Notified Bodies and other regulatory parties.
Without appointing an authorised representative, a non-EU manufacturer cannot legally place medical devices or IVDs on the European market. This requirement applies across a broad spectrum of products, from low-risk devices to advanced diagnostic technologies. The requirement exists before market entry, which means the representative must be appointed early in the compliance process rather than treated as a final administrative step. For companies preparing for European distribution, selecting the right EU Authorized Representative for Medical Devices and IVDs can significantly influence registration readiness, document management and long-term regulatory stability.
The Written Mandate Between Manufacturer and Representative
The relationship between the manufacturer and the EU Authorized Representative must be established through a written mandate. This mandate defines the tasks the representative is authorised to perform and confirms the obligations both parties must follow. It is a critical compliance record as it defines the scope of representation, responsibilities, communication roles and the actions required if compliance issues occur.
An unclear or weakly drafted mandate can cause uncertainty at critical moments, particularly during authority requests, inspections, complaint handling or corrective actions. A strong mandate should clearly describe how documents will be made available, how regulatory communication will be handled, how incident information will be shared and what happens if the manufacturer does not meet its duties. For this reason, the mandate should be prepared carefully and reviewed before device registration or market placement begins.
Label and Packaging Requirements
The name and address of the EU Authorized Representative must appear on the device label, packaging or related product information as required by the applicable regulation. This enables authorities, distributors, healthcare professionals and users to identify the local representative connected to the device. It also strengthens the representative’s role as the official European contact for a manufacturer based outside the European Union.
Accurate labelling is essential because incorrect or missing representative details can lead to compliance issues and possible delays in market access. Manufacturers should ensure that their artwork, instructions, declarations and registration information are aligned before products are released. If the representative changes, labelling and registration details may also need to be updated in a controlled and timely manner.
Documentation Review and Availability
A key responsibility of an EU Authorized Representative for Medical Devices and IVDs is to ensure that essential compliance documents are available and correctly prepared. This involves confirming the existence of the EU Declaration of Conformity, ensuring technical documentation is complete and verifying that the appropriate conformity assessment route has been followed based on device type and risk classification.
The representative may also need to hold or have access to copies of technical documentation, declarations and Notified Body certificates. These records must remain accessible for inspection by Competent Authorities for the specified retention period after the last device is marketed. This makes document control a central part of the relationship between manufacturer and representative. Manufacturers should keep records updated and ensure the representative can respond promptly to regulatory requests.
Communication With Competent Authorities and Notified Bodies
The EU Authorized Representative acts as the official eu-authorized-representative communication channel between the non-EU manufacturer and European regulatory authorities. If a Competent Authority requests information, samples, technical documentation or clarification, the representative is expected to support the response process. The representative may also liaise with Notified Bodies when necessary, particularly regarding certification, conformity assessments or corrective measures.
This communication function goes beyond simply passing messages. A reliable representative should understand regulatory expectations, keep accurate records and ensure that requests are handled within appropriate timelines. Delayed or incomplete responses can create serious issues for manufacturers, including market restrictions or further regulatory review. For this reason, manufacturers should work with a representative who has strong regulatory knowledge and clear internal processes.
Post-Market Surveillance and Incident Support
Medical device compliance does not end after market entry. Once a device is in use, manufacturers must continue monitoring performance, complaints, incidents and safety signals. The EU Authorized Representative has a role in supporting this post-market responsibility by passing complaints and incident information to the manufacturer without delay.
This is especially important when information comes from clinicians, patients, users, distributors or authorities. Timely communication helps the manufacturer assess whether further investigation, reporting, field safety action or corrective action is needed. A strong representative understands that post-market surveillance is not just paperwork. It plays a key role in patient safety, product enhancement and continued regulatory confidence.
Registration Responsibilities and EUDAMED
Within European regulatory frameworks, manufacturer and representative details must be registered as necessary. The EU Authorized Representative may assist with registering both manufacturer and representative data in EUDAMED. Accurate registration helps authorities identify responsible parties, review device information and maintain market oversight.
Manufacturers should prepare complete company details, device information, certificates and declarations before registration activities begin. Any mismatch between labelling, declarations, technical documentation and registration records may lead to delays or compliance concerns. The representative’s involvement helps ensure that required information is properly aligned and available when needed.
When the Representative Must Take Action
An EU Authorized Representative also carries responsibilities if the manufacturer does not fulfil regulatory requirements. If significant non-compliance arises and is not corrected by the manufacturer, the representative may need to terminate the mandate and notify relevant authorities and the Notified Body where relevant. This responsibility highlights that the role extends beyond administrative tasks.
The representative has legal accountability and cannot ignore major compliance failures. Manufacturers should therefore view the representative as a regulatory partner rather than a passive provider. Open communication, timely document updates and clear responsibility sharing help prevent misunderstandings and reduce risk during the product life cycle.
Choosing the Right EU Authorized Representative
Selecting an EU Authorized Representative should be done with care. Manufacturers should evaluate regulatory expertise, experience in medical devices and IVDs, document management capabilities, clear response processes and strong knowledge of European regulations. The representative should be able to support communication with authorities, maintain records and guide the manufacturer on practical compliance expectations.
Cost should not be the only factor. A weak representative can create delays, poor communication and unnecessary risk, while a capable representative can help maintain confidence throughout market entry and post-market activities. The correct selection provides non-EU manufacturers with a reliable European presence and enables smoother regulatory management.
Conclusion
An EU Authorized Representative is a mandatory requirement for non-EU manufacturers aiming to introduce medical devices or IVDs into the European market. The role covers legal representation, document availability, regulatory communication, complaint management, registration assistance and intervention in cases of serious non-compliance. Under the Medical Device Regulation and In Vitro Diagnostic Medical Device Regulation, appointing an authorised representative is not optional and should be completed before market placement begins. By choosing a competent EU Authorized Representative for Medical Devices and IVDs, manufacturers can strengthen compliance, support patient safety and build a reliable foundation for long-term access to the European market.